Thanks Rajenp5, was this in the melanoma trial? This is obviously starting to stretch my understanding of cancers but why would they be targeting proximal tumours in a melanoma trial?
Was this adverse reaction published anywhere? Surely they would not pursue further trials if there was a drug fail issue...
- Forums
- ASX - By Stock
- Qbiotics
Qbiotics, page-1251
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)